REQUIREMENTS FOR DIAGNOSIS OF PRENATAL CYTOMEGALOVIRUS-INFECTION BY AMNIOTIC-FLUID CULTURE

被引:18
作者
MULONGO, KN
LAMY, ME
VANLIERDE, M
机构
[1] UNIV CATHOLIQUE LOUVAIN,DEPT VIROL,B-1200 BRUSSELS,BELGIUM
[2] UNIV CATHOLIQUE LOUVAIN,DEPT OBSTET,B-1200 BRUSSELS,BELGIUM
来源
CLINICAL AND DIAGNOSTIC VIROLOGY | 1995年 / 4卷 / 03期
关键词
AMNIOTIC FLUID CULTURE; CONGENITAL CMV INFECTION; INTERVAL;
D O I
10.1016/0928-0197(95)00003-Q
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Amniotic fluid culture is considered to be the best method for the detection of antenatal cytomegalovirus (CMV) infection and prediction of congenital CMV infection. Recently, however, some false-negative results have been reported. Objectives: Prediction of congenital CMV infection by amniotic fluid culture with emphasis on false-negative results. Study design: Retrospective study of 42 pregnant women with primary CMV infection. First, estimation of seroconversion related to the gestational age was established. Afterwards, results of amniotic fluid culture were compared either with CMV isolation from biopsies from aborted fetuses, or with viral culture of newborns' urine. Results: In 18 cases (43%), amniotic fluid culture gave negative results which coincided with 18 uninfected newborns. In 18 other cases (43%), amniotic fluid culture was positive for CMV: 7 newborns with CMV viruria and 11 terminations of pregnancy with CMV isolated from fetal biopsies. In the remaining 6 cases, amniotic fluid culture gave negative results, whereas the 6 newborns were all infected. Conclusion: Amniotic fluid culture remains an accurate method for the diagnosis of CMV antenatal infection. However, in order to avoid false-negative results, the importance of a correct estimation of the gestational age of seroconversion and of a sufficient interval between primary infection and amniocentesis are stressed.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 15 条
[1]  
ALFORD C A, 1990, P1981
[2]   PRENATAL-DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS-INFECTION - FALSE-NEGATIVE AMNIOCENTESIS AT 20 WEEKS GESTATION [J].
CATANZARITE, V ;
DANKNER, WM .
PRENATAL DIAGNOSIS, 1993, 13 (11) :1021-1025
[3]  
CONBOY TJ, 1986, PEDIATRICS, V77, P801
[4]  
DONNER C, 1993, OBSTET GYNECOL, V82, P481
[5]   GANCICLOVIR - A REVIEW OF PHARMACOLOGY, THERAPEUTIC EFFICACY AND POTENTIAL USE FOR TREATMENT OF CONGENITAL CYTOMEGALO-VIRUS INFECTIONS [J].
FANHAVARD, P ;
NAHATA, MC ;
BRADY, MT .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1989, 14 (05) :329-340
[6]   THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667
[7]   SCHOOL FAILURE AND DEAFNESS AFTER SILENT CONGENITAL CYTOMEGALOVIRUS-INFECTION [J].
HANSHAW, JB ;
SCHEINER, AP ;
MOXLEY, AW ;
GAEV, L ;
ABEL, V ;
SCHEINER, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (09) :468-470
[8]   PRENATAL-DIAGNOSIS OF CYTOMEGALOVIRUS (CMV) INFECTION - A PRELIMINARY-REPORT [J].
HOGGE, WA ;
BUFFONE, GJ ;
HOGGE, JS .
PRENATAL DIAGNOSIS, 1993, 13 (02) :131-136
[9]  
HOHLFELD P, 1991, OBSTET GYNECOL, V78, P615
[10]   PRENATAL-DIAGNOSIS OF FETAL CYTOMEGALOVIRUS-INFECTION [J].
LAMY, ME ;
MULONGO, KN ;
GADISSEUX, JF ;
LYON, G ;
GAUDY, V ;
VANLIERDE, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (01) :91-94